Tecmoled
Tecmoled is an innovative start-up specializing in e-health, developing the OXYFLEX® device, a compact and wireless sensor that measures vital signs with high precision. The product differentiates itself by allowing non-invasive monitoring from the forehead, making it suitable for various medical fields including emergency care, geriatrics, and pediatrics. With features like real-time data transmission and integration into existing data systems, OXYFLEX® enhances patient monitoring and reduces the workload for healthcare professionals. The company collaborates with institutions like the University of Toulon to advance its AI systems, positioning itself strongly in the growing e-health market.
Tecmoled
Tecmoled is an innovative start-up specializing in e-health, developing the OXYFLEX® device, a compact and wireless sensor that measures vital signs with high precision. The product differentiates itself by allowing non-invasive monitoring from the forehead, making it suitable for various medical fields including emergency care, geriatrics, and pediatrics. With features like real-time data transmission and integration into existing data systems, OXYFLEX® enhances patient monitoring and reduces the workload for healthcare professionals. The company collaborates with institutions like the University of Toulon to advance its AI systems, positioning itself strongly in the growing e-health market.
TL;DR
Founded: 2019
Headquarters: Meyreuil, France
Product: OXYFLEX — wireless forehead oximetry sensor (SpO2, BPM) with real-time data transmission and AI-enabled monitoring
Target markets: Emergency care, geriatrics, pediatrics, at-risk workers, sleep apnea
Investors: Incubateur Impulse (recorded Apr 2019; amount undisclosed)
Employees: 2–10
Company Overview
Problem Domain
E-health / patient monitoring via patented forehead oximetry for clinical settings, at-risk workers, and sleep apnea monitoring.
Founded
2019
Industry
E-health
Funding Track Record
Amount not disclosed
Investor Signal
“Incubateur Impulse listed as an investor (Apr 2019)”